pneumococcal 13-valent conjugate vaccine
GPTKB entity
Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:administeredBy |
intramuscular injection
|
| gptkbp:alsoKnownAs |
gptkb:PCV13
|
| gptkbp:approvedBy |
gptkb:FDA
2010 |
| gptkbp:ATCCode |
gptkb:J07AL02
|
| gptkbp:brand |
gptkb:Prevnar_13
|
| gptkbp:broadcastOn |
multiple doses
|
| gptkbp:contains |
polysaccharide antigens
diphtheria CRM197 protein |
| gptkbp:contraindication |
severe allergic reaction to previous dose
|
| gptkbp:developedBy |
gptkb:Pfizer
|
| https://www.w3.org/2000/01/rdf-schema#label |
pneumococcal 13-valent conjugate vaccine
|
| gptkbp:numberOfSerotypes |
13
|
| gptkbp:protectedBy |
gptkb:Streptococcus_pneumoniae
|
| gptkbp:recommendation |
infants
young children adults over 65 |
| gptkbp:sideEffect |
fever
injection site pain irritability |
| gptkbp:storage |
2-8°C
|
| gptkbp:usedFor |
prevention of pneumococcal disease
|
| gptkbp:WHOModelListOfEssentialMedicines |
true
|
| gptkbp:bfsParent |
gptkb:pneumococcal_7-valent_conjugate_vaccine
|
| gptkbp:bfsLayer |
6
|